symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
NVTA,0.6208,1.782924,11781493,167895986,0,0.6-3.775,-0.0278,Invitae Corporation,USD,0001501134,US46185L1035,46185L103,New York Stock Exchange,NYSE,Diagnostics & Research,https://www.invitae.com,"Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was incorporated in 2010 and is headquartered in San Francisco, California.",Mr. Kenneth D. Knight,Healthcare,US,1700,415 374 7782,1400 16th Street,San Francisco,CA,94103,4.42764,6.96764,https://financialmodelingprep.com/image-stock/NVTA.png,2015-02-12,False,False,True,False,False
